Updated Nov. 16, 2012 at 7:29 a.m.

Premium Lock Drug failure triggers 76% crushing of Tranzyme stock

Published: 2012-11-15 11:52:00
Updated: 2012-11-16 07:29:49

Print this blog post

Shares in Tranzyme Pharma plummeted 76 percent Thursday after the RTP-based company announced failure of a drug that it hoped would treat diabetics suffering from gastroparesis....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science